A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated ...

Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.

Medtech startups struggle with funding as strategic buyers consolidate, preferring fully developed products over early ...

From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech ...

Discover how global tariffs are driving changes in medtech growth strategies, M&A activities, and manufacturing footprints.

Johnson & Johnson MedTech (NYSE:JNJ) today announced 12-month pilot data from a study of its investigational Omnypulse ...

J&J MedTech recalls neuro device following four injuries and one death linked to detachment failures in Cerepak coil systems.

CEO Brent Ness outlined a 2026 execution plan focused on reimbursement, evidence, and adoption. ・Monetization is underway ...

JERSEY CITY, N.J., Feb. 5, 2026 /PRNewswire/ -- Pure Global launches the first flat-fee pricing model in the MedTech industry for full-service medical device market access, designed to simplify ...

Medtech dealmaking rebounded last year, and, in 2026, M&A players are seeking to “outperform the next-best owner” amid softer valuations for assets. | Bain & Company’s new 2026 global M&A report found ...

TD Cowen analysts Mathew Blackman and Drew Ranieri have named their top three medtech picks under their evolving “Bones, Bots ...

ClariMed experts reveal how gender bias in medtech leads to safety risks for women and share strategies to create more ...